SWOG is 70 Years Strong! This year marks the 70th anniversary of the founding of the cooperative group that would go on to become the SWOG Cancer Research Network #SWOGonc @swog.org www.swog.org/.../2026/05/...
SWOG Cancer Research Network
@swog.org
SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956. Member NCTN & NCORP. Online at swog.org. @SupportingSWOG.bsky.social partner.
Lung-MAP investigators present 4 posters at #ASCO26. 1 is an analysis led by Dr. Diane Tseng of how the severity of immune-related adverse events (irAEs) in patients getting ICIs is associated with clinical outcomes: www.asco.org/abstracts-pr...
SWOG researchers give #ASCO26 oral presentations on results of 2 GI trials, a testicular cancer study, work on vit D & neuropathy, big-picture results from S1609 DART rare cancers trial, & an AI prediction model in breast cancer! @swog.org ASCO calendar is at swog.org/media/26051.
We want your great ideas! Our annual call for funding proposals has opened. Now through September 1, we welcome submissions from @swog.org members and collaborators #SWOGonc Learn more: conta.cc/4tSPFH3
Did you catch the recap from the @swog.org spring meeting? We made a big announcement honoring Dr. Blanke! (and there was cake 🍰) #SWOGonc www.swog.org/news-events/...
Excited for the @swog.org spring meeting, thanks to @supportingswog.bsky.social- kicking things off with the #palliative committee. #oncology #nurse #nursepractitioner #research #scientists
Composition of Health Care Contact Days and Mortality Prediction Among Older Adult Clinical Trial Participants. Co-authored by Dr. Arjun Gupta; Cathee Till, MS; Michael LeBlanc, PhD; @drdawnhershman.bsky.social; @drjoeunger.bsky.social. @supportingswog.bsky.social ascopubs.org/doi/abs/10.1...
Composition of Health Care Contact Days and Mortality Prediction Among Older Adult Clinical Trial Participants | JCO Oncology Practice
PURPOSEContact days exceeding trial protocol–mandated care may represent adverse clinical events and portend worse outcomes. Identifying patients at risk of poor outcomes could enable clinical teams t...
ascopubs.org
Apply by May 1: All #NCTN group members are eligible! @swog.org Virtual Grant Writing Workshop #SWOGonc conta.cc/3Qqnm4M
Thrilled and proud that our Hematology/Oncology Section Chief Dr. Smith has been selected as the Chair of @swog.org's lymphoma committee!! She is an incredible leader and very much deserves this honor!
"Lung-MAP is the most transformative & pivotal trial in the MET Crusaders right now." Hear MET Crusaders Chair Marcia K. Horn, JD, on 3 Lung-MAP studies for patients with advanced non-small cell #lungcancer with MET biomarkers. #lcsm #ClinicalTrials @focr.bsky.social www.youtube.com/watch?v=H1mx...
Why Lung MAP Matters for MET Lung Cancer Patients
YouTube video by Friends of Cancer Research
youtube.com
Team Hope showed up and gave it their all! 62 or 32 miles through the hills (and wind!) at the #TourDeScottsdale Every mile 🚴♀️ to advance @swog.org research #SWOGonc Proud of this crew! Grateful for everyone who donated & cheered us on 🙌 Watch the recap ⬇️ vimeo.com/1180550865?f...
Team Hope at the 2026 Tour de Scottsdale
The Hope Foundation's 3rd annual Team Hope Ride at the 2026 Tour de Scottsdale.
vimeo.com
A new chair for @swog.org 's lymphoma committee #SWOGonc "Please join us in welcoming Dr. Smith as chair of SWOG’s lymphoma committee, and in thanking outgoing chair Dr. Jonathan W. Friedberg for his visionary leadership of our lymphoma research effort." www.swog.org/news-events/...
A Changing of SWOG’s Lymphoma Guard | SWOG
After a national search chaired by our group statistician Dr. Mike LeBlanc, we have just selected Dr. Sonali M. Smith to be chair of SWOG’s lymphoma committee. Pending approval by the board of governo...
swog.org
S2409 PRISM is testing whether it’s feasible to identify each patient’s small cell #LungCancer subtype and use that information to select the best therapy for that patient. #SCLC Co-PI: Alberto Chiappori, MD @moffittnews.bsky.social swog.org/clinical-trials/S2409
Thank you to all riders, donors, and other supporters of @supportingswog.bsky.social and @swog.org in this event! And huge thanks to Dr. Parminder Singh for getting all of this rolling!
The Hope Foundation for Cancer Research@supportingswog.bsky.social · 4mo agoYou did it! Thank you to the cyclists, donors, friends and family who made this year's Team Hope ride at the Tour de Scottsdale an overwhelming success. We're honored to support @swog.org and its members, & especially on a day like last Saturday. Beautiful weather and smiles all around! #SWOGonc
From the @swog.org Front Line: SWOG Establishes An APP & Nurse Scientist Committee #SWOGonc "Drs. Myers and Braun-Inglis are, of course, the ideal leadership team for this committee..." We agree! 💯 Congrats to this powerhouse team! www.swog.org/news-events/...
Blog post from SWOG chairs @drdawnhershman.bsky.social & Primo N. Lara, MD: SWOG Establishes An APP & Nurse Scientist Cmte Our new cmte recognizes the contributions of APPs to our success & will help empower more of them to contribute to their full scope of practice. www.swog.org/news-events/...
March 20, 2026: FDA approves nivolumab + AVD combination for Stage III or IV classical Hodgkin lymphoma in patients 12 and older, based on results of phase 3 S1826 #NCTN NCI trial, led by SWOG Cancer Research Network @swog.org and Children's Oncology Group (COG): www.fda.gov/drugs/resour...
FDA approves nivolumab with chemotherapy for Hodgkin lymphoma
FDA approved approved nivolumab (Opdivo, Bristol Myers Squibb Company) with doxorubicin, vinblastine, and dacarbazine (AVD) for cHL.
fda.gov
Front Line post from @swog.org group chairs @drdawnhershman.bsky.social & Primo N. Lara, MD: The Next Era of SWOG Success In our vision, we focus even more intensively on studies that tackle the vital questions only public-powered research will answer. www.swog.org/news-events/...
Our @swog.org Chairs' blog: A Team Science Leadership Team SWOG is all about interdisciplinary collaboration and team science. We think a leadership approach with dual principal investigators who bring complementary skillsets and expertise to the role is a great fit. www.swog.org/news-events/...
Saying Thank You: Dr. Charles Blanke's last Front Line post as chair of @swog.org: "I have been honored to serve as chair of this research group over the last 13 years, and I could not be prouder of what you have accomplished in that time." www.swog.org/news-events/...
Follicular lymphoma has long been deemed incurable. New findings from a 15-year follow-up analysis of clinical trial patients with follicular lymphoma could upend that prediction. @mshadman.bsky.social @swog.org Read more: https://bit.ly/4rIb59x
At @ascocancer.bsky.social #GU26, results from @swog.org S1602 ph 3 trial to evaluate BCG strain differences & intradermal BCG priming in high-grade NMIBC: finds Tokyo BCG is non-inferior to TICE BCG & could mitigate BCG shortage. #BladderCancer In UroToday at www.urotoday.com/conference-h...
ASCO GU 2026: SWOG S1602: A Phase III Randomized Trial to Evaluate BCG Strain Differences and Priming with Intradermal BCG Before Intravesical Therapy for BCG-Naïve High-Grade Non-Muscle Invasive Blad...
ASCO GU 2026, non-muscle invasive bladder cancer (NMIBC), SWOG S1602, Intradermal BCG Before Intravesical Therapy.
urotoday.com
15-year results from @swog.org S0016 trial suggest follicular lymphoma is curable. Cure modeling estimates a 42% cure rate among S0016 patients. Relapse rates drop markedly over time. Study is in Feb 26 @jamaoncology.com @wilmotcancer.bsky.social @fredhutch.org jamanetwork.com/journals/jam...
Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy
This secondary analysis examines 15-year follow-up data from a randomized clinical trial to evaluate the potential for long-term remission and cure for follicular lymphoma following chemoimmunotherapy...
jamanetwork.com
Registration is open for SWOG's spring group meeting, April 30-May 2, in San Francisco! Incoming Group Chairs Drs. Primo Lara, Jr., & Dawn Hershman invite SWOG members to bring questions, concerns, & ideas to an interactive town hall-style plenary, Friday, May 1, 2-4pm PT. Details: swog.org/Sp26mtg
The latest @swog.org Front Line: A Cancer Research Agenda for the Nation, and for SWOG #SWOGonc www.swog.org/news-events/...
A Cancer Research Agenda for the Nation, and for SWOG | SWOG
Among academic journals, none has a higher journal impact factor than CA: A Cancer Journal for Clinicians, published by the American Cancer Society.
swog.org
"Cancer statistics, 2026: Charting a course for a national cancer research agenda," commentary by Dr. Primo Lara, Jr, & @drdawnhershman.bsky.social publ w the annual portrait of U.S. #cancer stats in CA: A Cancer Journal for Clinicians, just out! #NCTN #NCORP @eaonc.bsky.social @nrgonc.bsky.social
Cancer statistics, 2026: Charting a course for a national cancer research agenda
Click on the article title to read more.
doi.org
S2213 is a randomized ph 3 to definitively learn role of transplant in pts newly diagnosed w AL #amyloidosis. BMT-CTN Champion: Anita D'Souza, MD SWOG.org/clinical-trials/S2213
Treated for muscle invasive bladder cancer and want to keep your bladder? Ask your doctor about #ClinicalTrial S2427 (BRIGHT). SWOG.org/S2427. 1-800-4-CANCER. #KeepMyBladder #MIBC
